Fingerprint
Dive into the research topics of 'Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer’s Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically